Quidel Corporation (QDEL)
News
| May 31 | Quidel to Present at Upcoming Conferences Marketwire |
| May 21 | QUIDEL CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change... |
| May 08 | Great week for TE! closed $HLX $LINE shorts, $SCHL $QDEL longs for avg 5-day mkt neutral return of 4.2%! by TrendExhaustion |
| May 04 | $QDEL 200 Day SMA Cross - Price crossed above 200 day SMA (15.9292). Confirmed by volume. by TradeIdeasQuant |
| May 03 | $QDEL Canaccord Genuity raises its price target $4 to $25 on Buy-rated Quidel (March 26, 2012 9:09 AM) that's 60% upside. by nucats |
| May 03 | $QDEL rsi(2) = 0.0077. oversold. tsf(5,9&15) under pps. yes js, time for bounce. popped up on my 'fat pitch' filter on stockfetcher by nucats |
| May 02 | $QDEL looking pretty oversold here. Looking for a short term bounce. by ScholzCapital |
| Apr 30 | QUIDEL CORP /DE/ Files SEC form 10-Q, Quarterly Report |
| Apr 27 | Quidel Whiffs on Revenues |
| Apr 26 | New Star Analyst Rankings for Quidel Corporation |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Diagnostic Substances
Quidel Corporation serves to enhance the health and well being of people around the globe through the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point of care (POC) in infectious diseases and reproductive health. Marketed under the leading brand name of QuickVue®, the portfolio currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, infectious mononucleosis, H. pylori and Chlamydia. The firm sells products to physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics and wellness screening centers. It was founded in 1979 and is headquartered in San Diego, California.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Quidel Corporation is up 2.54% over the last year vs S&P 500 Total Return up 0.88%, Meridian Bioscience down 17.16%, and Accelr8 Technology down 51.98%.
- QDEL Total Returns
- ^SPXTR Total Returns
- VIVO Total Returns
- AXK Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these QDEL related companies
Pro Strategies Featuring QDEL
Did Quidel Corporation make it into our Pro Portfolio Strategies?
QDEL Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other QDEL Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| QDEL | 15.72 | +0.18 | +1.16% | 513.91M |
| QCRH | 11.97 | +0.10 | +0.80% | 56.41M |
| QCOR | 41.40 | -0.16 | -0.39% | 2.643B |
| QCOM | 57.31 | -0.14 | -0.24% | 97.17B |
| QCCO | 4.090 | -0.00 | -0.00% | 70.51M |
| QBC | 0.27 | -0.03 | -10.00% | 23.05M |
| QBAK | 1.94 | +0.00 | +0.00% | 23.76M |
| QAI | 27.30 | +0.07 | +0.26% | |
| PW | 8.95 | +0.25 | +2.87% | 14.09M |
| PVTB | 14.73 | -0.08 | -0.54% | 1.073B |
